Thanks to a $2.7 million National Cancer Institute grant, radiation oncologist Arta Monjazeb and his team will study how obesity makes tumors more resistant to radiotherapy.
Read MoreUC Davis Health biophysical chemist Robert Fairclough’s lab has developed a molecule that could generate a better diagnostic test and therapies for the autoimmune disease myasthenia gravis.
Read MoreA new UC Davis study reveals the interaction between tumor microbiome and the immune system may be the secret to improving outcomes for sarcoma patients.
Read MoreUC Davis sarcoma researchers are part of an international team of scientists working to uncover the genetics behind a deadly cancer that is more common in children.
Read MoreUC Davis Health’s Department of Surgery has received a multimillion dollar grant to establish a National Center for Metabolic Phenotyping of Mouse Models of Obesity and Diabetes.
Read MoreUC Davis rehabilitation specialists tested a 3D markerless motion analysis technology’s ability to identify potential neurological conditions and monitor disease progression in patients in community settings.
Read MoreUC Davis Health researchers assessed the carbon footprint and potential savings in lives, costs and time of telehealth visits during the pandemic’s first two years.
Read MoreFindings from a UC Davis Comprehensive Cancer Center study prompt researchers to question current cervical cancer screening guidelines for older women.
Read MoreUC Davis Health was one of seven Level 1 trauma centers to participate in a study that looked at how often alcohol and drugs are involved in serious crashes.
Read MoreImmunologist William Murphy discusses CAR T-cell cancer therapy and his work with Caring Cross, CIRM and UC Davis researchers to find novel cures to leukemia and lymphoma.
Read MoreAn American College of Surgeons quality improvement program reduced surgical wait times and cut hospital stays by more than a day.
Read MoreA new study looks at cancer deaths in California due to tobacco, sounding the alarm regarding the tragic loss of life caused by tobacco addiction.
Read MoreCIRM awarded UC Davis’ Alpha Stem Cell Clinic an $8 million grant renewal to expand its successful clinical trials operation and advance toward onsite manufacturing of therapies.
Read MoreFive UC Davis Health faculty members have been recognized in Research.com's 2022 ranking of the Top 1000 Female Scientists in the World.
Read MoreA partnership between UC Davis Comprehensive Cancer Center and UC Davis School of Veterinary Medicine hopes to help cure cancer in both people and pets.
Read MoreA new UC Davis MIND Institute study finds the NIH Toolbox Cognition Battery is a promising option for measuring cognitive change in people with intellectual disability.
Read MoreInfectious diseases expert George Thompson warns of the rising threat and apparent spread of disease-causing fungi outside their traditional hot spots. Fungal lung infections are commonly misdiagnosed, leading to delays in treatment and increase in antimicrobial resistance in the community.
Read MoreThe Department of Emergency Medicine has been awarded two National Institutes of Health grants totaling over $5 million to improve patient care. They include an effort to better evaluate pediatric trauma patients and another to identify effective treatments early in emergency care.
Read MoreA Sacramento woman celebrates the 100th dose of a clinical trial therapy that has left her cancer free. The Phase II clinical trial at UC Davis Comprehensive Cancer Center combines two immunotherapy drugs that lower toxicity and lengthen remission.
Read MoreA team led by Diana Miglioretti, chief of biostatistics at UC Davis, won a $15 million NCI grant to develop models and use artificial intelligence to make breast cancer screening and surveillance more accurate and equitable.
Read MoreA UC Davis Comprehensive Cancer Center researcher helped lead a new study that may prompt medical experts to rethink when to start mammograms for women who have a mother, sister or daughter diagnosed with breast cancer.
Read MoreA new study by researchers at UC Davis Children’s Hospital uses the first randomized controlled trial to evaluate PC-CARE’s effectiveness for children with challenging behaviors and their parents or caregivers. The study’s findings were recently published in the Journal of Child Psychiatry Human Development.
Read MoreThree babies have been born after receiving the world’s first spina bifida treatment combining surgery with stem cells. This was made possible by a landmark clinical trial at UC Davis Health known formally as the “CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele.”
Read MoreShellfish is the leading cause of food allergy in the U.S. In this Q& A, Patrick Leung, professor of rheumatology, allergy and clinical immunology at UC Davis Health, answers questions on the latest advances in diagnosing and treating shellfish allergies.
Read MoreContext shapes our perception of facial expressions during everyday social interactions. A recent UC Davis Health study identified where in the brain these neural computations take place and how, based on context, the different parts of the brain interact to determine facial perception.
Read MoreThe National Center for Interventional Biophotonic Technologies hosted its inaugural symposium September 29 and 30, bringing together leading researchers from 13 institutions. The light-based technologies being developed have the potential to transform how diseases are diagnosed, managed, and treated.
Read MoreUC Davis Health neuroscientist Sergey Stavisky was selected by the National Institutes of Health to receive the 2022 NIH Director’s New Innovator Award. The $2.3 million award will fund his research on medical devices implanted in the brain to restore speech.
Read MoreUC Davis Health researchers received a $1.05 million grant from the Centers for Disease Control and Prevention to identify risk and protective factors linked to the combined use of opioids and benzodiazepines, a group of drugs used to treat anxiety and insomnia.
Read MoreTwo recent UC Davis studies reveal how skin forms differently across different areas of the body from the face and underarms to the palms of our hands and feet. By profiling the changes in skin, researchers found that the differences have a direct impact for how various skin diseases form across the body.
Read MoreWhen an injury doesn’t heal correctly, fibrosis and scar tissue form in the muscles. A UC Davis team may have unlocked a way to prevent muscular fibrosis by preventing stem cells from getting stuck in an endless loop of collagen production.
Read More